Ely Benaim
2017
In 2017, Ely Benaim earned a total compensation of $621.8K as Chief Medical Officer at Rexahn Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,000 |
|---|---|
| Option Awards | $51,987 |
| Salary | $400,000 |
| Stock Awards | $17,480 |
| Other | $16,300 |
| Total | $621,767 |
Benaim received $400K in salary, accounting for 64% of the total pay in 2017.
Benaim also received $136K in non-equity incentive plan, $52K in option awards, $17.5K in stock awards and $16.3K in other compensation.
Rankings
In 2017, Ely Benaim's compensation ranked 11,063rd out of 14,666 executives tracked by ExecPay. In other words, Benaim earned more than 24.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,063 out of 14,666 | 25th |
Division Manufacturing | 4,327 out of 5,772 | 25th |
Major group Chemicals And Allied Products | 1,566 out of 2,075 | 25th |
Industry group Drugs | 1,286 out of 1,731 | 26th |
Industry Pharmaceutical Preparations | 1,003 out of 1,333 | 25th |
Source: SEC filing on April 23, 2018.
Benaim's colleagues
We found three more compensation records of executives who worked with Ely Benaim at Rexahn Pharmaceuticals in 2017.